Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Translational Immunodiagnostics in Suspected Stroke (TrImS): A Two-centre, Pragmatic, Prospective, Observational Study

NCT05300997 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT05300997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05300997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Translational Immunodiagnostics in Suspected Stroke (TrImS): A Two-centre, Pragmatic, Prospective, Observational Study
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2022
Completion date
August 31, 2027
Enrollment
650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, atrial fibrillation, cardioembolic stroke, haemorrhagic stroke, large-artery atherosclerosis (embolus/thrombosis), small vessel disease, stroke of anterior cerebral artery, stroke of basilar artery, stroke of middle cerebral artery, stroke of other determined etiology, stroke of undetermined etiology, transient ischemic attacks